Results 141 to 150 of about 2,155 (206)

Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy. [PDF]

Am J Ophthalmol, 2020
Kempen JH, Van Natta ML, Friedman DS, Altaweel MM, Ansari H, Dunn JP, Elner SG, Holbrook JT, Lim LL, Sugar EA, Jabs DA, Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group.   +11 more
europepmc   +1 more source

The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience. [PDF]

J Ophthalmic Inflamm Infect
Kozak I, Gurbaxani A, Pandova M.
europepmc   +1 more source

Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center. [PDF]

Biomedicines
Abu Arif J, Knecht VA, Rübsam A, Lussac V, Jami Z, Pohlmann D, Müller B, Pleyer U.   +7 more
europepmc   +1 more source

Real-world safety and efficacy of 0.19 mg fluocinolone acetonide intravitreal implant in the management of recurrent non-infectious uveitis [PDF]

, 2022
Christensen, Louise Fischer, Vorum, Henrik   +1 more
core   +3 more sources

Efficacity and Safety of the Fluocinolone Acetonide Implant in Uveitic Macular Edema: A Real-Life Study from the French Uveitis Network. [PDF]

J Pers Med
Jabbour M, Kodjikian L, Bourdin A, Rougier MB, Serrar Y, Weber M, Massé H, Mazhar D, Perez-Roustit S, Chiquet C, Delyfer MN, Bodaghi B, Touhami S.   +12 more
europepmc   +1 more source

Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema - A Single Center Study. [PDF]

Clin Ophthalmol
Soares RM, Ferreira CC, Fernandes JDS, Madeira C, Silva LMA, Saraiva E, Ribeiro L, Fonseca S.   +7 more
europepmc   +1 more source

Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN^®). [PDF]

Int Med Case Rep J, 2020
Pessoa B, Melo-Beirão J, Meireles A, Menéres P.   +3 more
europepmc   +1 more source

Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber

JAMA Ophthalmology, 2020
Li, Angela S., Nguyen, Huy V., Do, Diana V.   +2 more
openaire   +2 more sources

Determining the relative cost effectiveness of the fluocinolone acetonide intravitreal implant [PDF]

Current Medical Research and Opinion, 2017
openaire   +2 more sources

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema. [PDF]

Ophthalmol Ther, 2019
Eaton A, Koh SS, Jimenez J, Riemann CD.
europepmc   +1 more source